Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO - Euronext Amsterdam - NL0012059018 - Common Stock - Currency: EUR

87.65  +0.85 (+0.98%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXO. EXO was compared to 47 industry peers in the Financial Services industry. While EXO has a great profitability rating, there are some minor concerns on its financial health. EXO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

EXO had positive earnings in the past year.
EXO had a positive operating cash flow in the past year.
Of the past 5 years EXO 4 years were profitable.
In the past 5 years EXO always reported a positive cash flow from operatings.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

With an excellent Return On Assets value of 34.55%, EXO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EXO has a Return On Equity of 38.39%. This is amongst the best in the industry. EXO outperforms 91.49% of its industry peers.
EXO's Return On Invested Capital of 26.91% is amongst the best of the industry. EXO outperforms 95.74% of its industry peers.
EXO had an Average Return On Invested Capital over the past 3 years of 13.67%. This is above the industry average of 10.14%.
The 3 year average ROIC (13.67%) for EXO is below the current ROIC(26.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROIC 26.91%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

EXO has a better Profit Margin (95.30%) than 97.87% of its industry peers.
In the last couple of years the Profit Margin of EXO has grown nicely.
The Operating Margin of EXO (96.43%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of EXO has grown nicely.
With an excellent Gross Margin value of 100.00%, EXO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EXO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 96.43%
PM (TTM) 95.3%
GM 100%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXO is creating value.
EXO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXO has less shares outstanding
Compared to 1 year ago, EXO has an improved debt to assets ratio.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

EXO has an Altman-Z score of 5.47. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
EXO has a better Altman-Z score (5.47) than 82.98% of its industry peers.
The Debt to FCF ratio of EXO is 87.02, which is on the high side as it means it would take EXO, 87.02 years of fcf income to pay off all of its debts.
EXO has a Debt to FCF ratio of 87.02. This is in the lower half of the industry: EXO underperforms 72.34% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, EXO is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Altman-Z 5.47
ROIC/WACC5.73
WACC4.7%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

EXO has a Current Ratio of 0.19. This is a bad value and indicates that EXO is not financially healthy enough and could expect problems in meeting its short term obligations.
EXO's Current ratio of 0.19 is on the low side compared to the rest of the industry. EXO is outperformed by 74.47% of its industry peers.
A Quick Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
EXO has a Quick ratio of 0.19. This is in the lower half of the industry: EXO underperforms 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 262.89% over the past year.
The Earnings Per Share has been growing by 38.47% on average over the past years. This is a very strong growth
EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -65.59%.
The Revenue for EXO have been decreasing by -36.03% on average. This is quite bad
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%

3.2 Future

EXO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.89% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.31 indicates a rather cheap valuation of EXO.
Based on the Price/Earnings ratio, EXO is valued cheaply inside the industry as 95.74% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of EXO to the average of the S&P500 Index (27.28), we can say EXO is valued rather cheaply.
EXO is valuated reasonably with a Price/Forward Earnings ratio of 11.26.
EXO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXO is cheaper than 70.21% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. EXO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 1.31
Fwd PE 11.26
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXO is valued cheaper than 93.62% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXO indicates a slightly more expensive valuation: EXO is more expensive than 72.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 412.1
EV/EBITDA 1.56
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

EXO has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as EXO's earnings are expected to decrease with -49.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%

More info and screens

2

5. Dividend

5.1 Amount

EXO has a yearly dividend return of 0.59%, which is pretty low.
EXO's Dividend Yield is comparable with the industry average which is at 3.85.
With a Dividend Yield of 0.59, EXO pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

0.67% of the earnings are spent on dividend by EXO. This is a low number and sustainable payout ratio.
The Dividend Rate of EXO has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0.67%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

More info and screens

EXOR NV

AMS:EXO (7/3/2025, 1:46:58 PM)

87.65

+0.85 (+0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-17 2025-09-17
Inst Owners26.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap19.37B
Analysts85
Price Target118.61 (35.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP0.67%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.12%
PT rev (3m)-5.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.31
Fwd PE 11.26
P/S 1.26
P/FCF 412.1
P/OCF 412.1
P/B 0.51
P/tB 0.51
EV/EBITDA 1.56
EPS(TTM)66.88
EY76.3%
EPS(NY)7.79
Fwd EY8.88%
FCF(TTM)0.21
FCFY0.24%
OCF(TTM)0.21
OCFY0.24%
SpS69.67
BVpS172.92
TBVpS172.92
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROCE 35.89%
ROIC 26.91%
ROICexc 27.01%
ROICexgc 27.03%
OM 96.43%
PM (TTM) 95.3%
GM 100%
FCFM 0.31%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
ROICexc(3y)14.71%
ROICexc(5y)10.09%
ROICexgc(3y)16.03%
ROICexgc(5y)11.47%
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexcg growth 3Y82.33%
ROICexcg growth 5Y13.41%
ROICexc growth 3Y91.95%
ROICexc growth 5Y26.23%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Debt/EBITDA 0.2
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 170.63
Cash Conversion 0.32%
Profit Quality 0.32%
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 5.47
F-Score6
WACC4.7%
ROIC/WACC5.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y139.47%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.63%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-99.25%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%